Company registration number 06207816 (England and Wales)
SCHNATTERBECK MEDICAL SERVICES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023
PAGES FOR FILING WITH REGISTRAR
SCHNATTERBECK MEDICAL SERVICES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
SCHNATTERBECK MEDICAL SERVICES LIMITED
BALANCE SHEET
AS AT
30 APRIL 2023
30 April 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
4,462
1,368
Current assets
Debtors
11,523
-
0
Cash at bank and in hand
127,570
110,900
139,093
110,900
Creditors: amounts falling due within one year
(54,665)
(56,231)
Net current assets
84,428
54,669
Total assets less current liabilities
88,890
56,037
Provisions for liabilities
(1,115)
-
0
Net assets
87,775
56,037
Capital and reserves
Called up share capital
4
100
100
Profit and loss reserves
87,675
55,937
Total equity
87,775
56,037

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 20 February 2024
P Schnatterbeck
Director
Company registration number 06207816 (England and Wales)
SCHNATTERBECK MEDICAL SERVICES LIMITED
NOTES TO THE  FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023
- 2 -
1
Accounting policies
Company information

Schnatterbeck Medical Services Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Leman Street, London, United Kingdom, E1W 9US

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
50% Straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Taxation

The tax expense represents the sum of the tax currently payable.

SCHNATTERBECK MEDICAL SERVICES LIMITED
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
1
Accounting policies
(Continued)
- 3 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
4
4
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 May 2022
2,948
Additions
4,702
Disposals
(1,041)
At 30 April 2023
6,609
Depreciation and impairment
At 1 May 2022
1,580
Depreciation charged in the year
1,608
Eliminated in respect of disposals
(1,041)
At 30 April 2023
2,147
Carrying amount
At 30 April 2023
4,462
At 30 April 2022
1,368
SCHNATTERBECK MEDICAL SERVICES LIMITED
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2023
- 4 -
4
Called up share capital
2023
2022
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary shares of £1 each
100
100
100
100
5
Related party transactions

At the year end the company owed £31,507 (2022 - £30,097) to P Schnatterbeck, the director of the company, in respect of an interest free loan which is repayable on demand.

2023-04-302022-05-01falseCCH SoftwareCCH Accounts Production 2024.100No description of principal activityP Schnatterbeckfalsefalse062078162022-05-012023-04-30062078162023-04-30062078162022-04-3006207816core:OtherPropertyPlantEquipment2023-04-3006207816core:OtherPropertyPlantEquipment2022-04-3006207816core:CurrentFinancialInstrumentscore:WithinOneYear2023-04-3006207816core:CurrentFinancialInstrumentscore:WithinOneYear2022-04-3006207816core:ShareCapital2023-04-3006207816core:ShareCapital2022-04-3006207816core:RetainedEarningsAccumulatedLosses2023-04-3006207816core:RetainedEarningsAccumulatedLosses2022-04-3006207816core:ShareCapitalOrdinaryShares2023-04-3006207816core:ShareCapitalOrdinaryShares2022-04-3006207816bus:Director12022-05-012023-04-3006207816core:ComputerEquipment2022-05-012023-04-30062078162021-05-012022-04-3006207816core:OtherPropertyPlantEquipment2022-04-3006207816core:OtherPropertyPlantEquipment2022-05-012023-04-3006207816bus:OrdinaryShareClass12023-04-3006207816bus:OrdinaryShareClass12022-05-012023-04-3006207816bus:PrivateLimitedCompanyLtd2022-05-012023-04-3006207816bus:SmallCompaniesRegimeForAccounts2022-05-012023-04-3006207816bus:FRS1022022-05-012023-04-3006207816bus:AuditExempt-NoAccountantsReport2022-05-012023-04-3006207816bus:FullAccounts2022-05-012023-04-30xbrli:purexbrli:sharesiso4217:GBP